JP2005532374A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532374A5 JP2005532374A5 JP2004518242A JP2004518242A JP2005532374A5 JP 2005532374 A5 JP2005532374 A5 JP 2005532374A5 JP 2004518242 A JP2004518242 A JP 2004518242A JP 2004518242 A JP2004518242 A JP 2004518242A JP 2005532374 A5 JP2005532374 A5 JP 2005532374A5
- Authority
- JP
- Japan
- Prior art keywords
- coating
- coating suspension
- osmopolymer
- suspension
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000011248 coating agent Substances 0.000 claims 36
- 238000000576 coating method Methods 0.000 claims 36
- 239000000725 suspension Substances 0.000 claims 27
- 239000002552 dosage form Substances 0.000 claims 9
- 230000003204 osmotic effect Effects 0.000 claims 7
- 239000002904 solvent Substances 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- -1 Natrasol Polymers 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 238000013270 controlled release Methods 0.000 claims 2
- 239000002357 osmotic agent Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 239000013583 drug formulation Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229920000578 graft copolymer Polymers 0.000 claims 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39277502P | 2002-06-28 | 2002-06-28 | |
| PCT/US2003/021361 WO2004002450A1 (en) | 2002-06-28 | 2003-06-28 | Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532374A JP2005532374A (ja) | 2005-10-27 |
| JP2005532374A5 true JP2005532374A5 (https=) | 2006-08-03 |
Family
ID=30000934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004518242A Withdrawn JP2005532374A (ja) | 2002-06-28 | 2003-06-28 | 放出制御投薬形態物における発泡性浸透性組成物の形成のための（オスモポリマー、浸透剤を含んでなる）コーティング懸濁液ならびにこの浸透性コーティングを設けるための対応する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7338663B2 (https=) |
| EP (1) | EP1528913A1 (https=) |
| JP (1) | JP2005532374A (https=) |
| KR (1) | KR20050071375A (https=) |
| CN (1) | CN1678292A (https=) |
| AR (1) | AR040301A1 (https=) |
| AU (1) | AU2003248868A1 (https=) |
| CA (1) | CA2490683A1 (https=) |
| IL (1) | IL165864A0 (https=) |
| MX (1) | MXPA05000207A (https=) |
| NO (1) | NO20050181L (https=) |
| NZ (1) | NZ537343A (https=) |
| TW (1) | TW200414900A (https=) |
| WO (1) | WO2004002450A1 (https=) |
| ZA (1) | ZA200500826B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| ZA200711123B (en) | 2005-06-27 | 2009-08-26 | Biovail Lab Int Srl | Modified-release formulations of a bupropion salt |
| CA2655596C (en) * | 2006-06-27 | 2011-10-25 | Biovail Laboratories International Srl | Multiparticulate osmotic delivery system |
| US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
| US20090004281A1 (en) * | 2007-06-26 | 2009-01-01 | Biovail Laboratories International S.R.L. | Multiparticulate osmotic delivery system |
| US20110052655A1 (en) * | 2007-08-08 | 2011-03-03 | Wilson Kurt Whitekettle | Methods and vesicles for controlling protozoa |
| US7824557B2 (en) * | 2007-08-08 | 2010-11-02 | General Electric Company | Method for controlling microbial biofilm in aqueous systems |
| US7785478B2 (en) * | 2007-08-08 | 2010-08-31 | General Electric Company | Method for controlling protozoa that harbor bacteria |
| US8784659B2 (en) * | 2007-08-08 | 2014-07-22 | General Electric Company | Method for controlling microbial biofilm in aqueous systems |
| CN102871982B (zh) | 2012-10-16 | 2014-09-10 | 中国科学院上海药物研究所 | 一种药物渗透泵制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US36472A (en) * | 1862-09-16 | Cttlvebt | ||
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US5324280A (en) | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
| US5443459A (en) | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
| US5800422A (en) * | 1995-06-02 | 1998-09-01 | Alza Corporation | Osmotic device with delayed activation of drug delivery and complete drug release |
| PT1140012E (pt) * | 1998-12-17 | 2004-05-31 | Alza Corp | Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas |
| US6352721B1 (en) | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
-
2003
- 2003-06-27 TW TW92117738A patent/TW200414900A/zh unknown
- 2003-06-27 AR ARP030102341A patent/AR040301A1/es not_active Application Discontinuation
- 2003-06-28 KR KR1020047021455A patent/KR20050071375A/ko not_active Withdrawn
- 2003-06-28 CN CNA038206978A patent/CN1678292A/zh active Pending
- 2003-06-28 US US10/609,061 patent/US7338663B2/en not_active Expired - Lifetime
- 2003-06-28 JP JP2004518242A patent/JP2005532374A/ja not_active Withdrawn
- 2003-06-28 AU AU2003248868A patent/AU2003248868A1/en not_active Abandoned
- 2003-06-28 NZ NZ537343A patent/NZ537343A/en not_active IP Right Cessation
- 2003-06-28 IL IL16586403A patent/IL165864A0/xx unknown
- 2003-06-28 EP EP03762340A patent/EP1528913A1/en not_active Withdrawn
- 2003-06-28 MX MXPA05000207A patent/MXPA05000207A/es not_active Application Discontinuation
- 2003-06-28 CA CA002490683A patent/CA2490683A1/en not_active Abandoned
- 2003-06-28 WO PCT/US2003/021361 patent/WO2004002450A1/en not_active Ceased
-
2005
- 2005-01-12 NO NO20050181A patent/NO20050181L/no not_active Application Discontinuation
- 2005-01-27 ZA ZA200500826A patent/ZA200500826B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1001101A5 (fr) | Forme de dosage pour le traitement des maladies cardiovasculaires. | |
| JP4100910B2 (ja) | ヒドロゲル駆動の薬物剤形 | |
| CA2307037C (en) | Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production | |
| KR920008701B1 (ko) | 비대칭막을 사용한 전달수단 | |
| EP0711146B1 (en) | Osmotic device having a vapor-permeable coating | |
| FI110160B (fi) | Molekyylipainoltaan erilaisia polymeerejä ja lääkeainetta sisältävän annosmuodon valmistusmenetelmä | |
| CN101360485B (zh) | 作为胶囊填充物的基于亲水性载体的双重控释基质系统 | |
| US8173158B2 (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| JP5425058B2 (ja) | アルギン酸塩体を含む胃内滞留型システム | |
| US6649187B2 (en) | Use of polyalkylamine polymers in controlled release devices | |
| Wang et al. | Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects | |
| JP2003513906A5 (https=) | ||
| RU2376983C2 (ru) | Гастроретентивные композиции и способ их изготовления | |
| CN1678290A (zh) | 提高控释药物组合物溶解度的方法和剂型 | |
| JP2005532374A5 (https=) | ||
| US8956654B2 (en) | Sustained release dosage form | |
| Philip et al. | Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil | |
| Waterman et al. | Osmotic capsules: a universal oral, controlled-release drug delivery dosage form | |
| KR20130067255A (ko) | 경구 투여 형태 | |
| Chauhan et al. | Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: Optimization by central composite design | |
| JP2024501051A (ja) | 持続放出ウパダシチニブ配合物 | |
| KR20040083492A (ko) | 삼투성 전달 시스템 | |
| CN104873457A (zh) | 缓释剂型 | |
| JP2005533084A (ja) | 液体の有効成分の製剤を含んでなりかつ膨張可能な浸透圧組成物によりその放出を制御する経口の投薬形態 | |
| Mishra et al. | Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug |